Wang Chao, Wang Jun, Wang Bin, Jing Xinhua, Huang Ye
Department of Cardiothoracic Surgery, Changzhou First People's Hospital, Changzhou 213003, Jiangsu, China. Corresponding author: Wang Bin, Email:
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018 Dec;30(12):1173-1177. doi: 10.3760/cma.j.issn.2095-4352.2018.012.014.
To investigate the effect of enteral nutrition (EN) tolerance assessment standardized process management on nosocomial infection and prognosis in patients with tracheotomy and long-term mechanical ventilation (MV) in intensive care unit (ICU).
A prospective cohort study was conducted. Forty-six patients who required long-term MV due to tracheotomy admitted to ICU of Changzhou First People's Hospital from January 2015 to December 2017 were enrolled. Taking the standardized process management of EN tolerance assessment from June 30th, 2016 as the time spot, patients admitted from January 1st, 2015 to June 30th, 2016 were taken as the control group (25 cases) and patients admitted from July 1st, 2016 to December 31st, 2017 as the observation group (21 cases). The two groups were all given conventional EN treatment and conventional symptomatic supportive treatment. Patients in the observation group was given the EN tolerance standardized process management, and received the nutritional risk screening score. While the control group was given a conventional EN management protocol (nurses routinely reported to the doctor and then gave further action). The nutritional support related indicators within 30 days of treatment (including serum albumin, serum pre-albumin, serum cholinesterase), the EN feeding tolerance index (the average amount of gastrointestinal motility drugs used within 30 days, the average EN interruption time per patient, and the incidence of gastrointestinal bleeding) and the prognosis-related indicators [including the incidence of ventilator-associated pneumonia (VAP), the monthly average hospitalization cost, the proportion of drugs, and the ratio of antibiotics to drugs] were compared.
Compared with the control group, serum albumin, pre-albumin and cholinesterase were significantly increased in the observation group [albumin (g/L): 32.86±4.83 vs. 28.16±3.62, pre-albumin (mg/L): 186.42±62.84 vs. 163.26±73.49, cholinesterase (U/L): 3 482.34±369.92 vs. 2 986.86±491.49, all P < 0.05], the average use of gastrointestinal motility drugs was significantly reduced (mg: 11.20±3.86 vs. 15.23±5.68, P < 0.05), the average EN interruption time was significantly longer in each patient (hours: 6.38±3.59 vs. 4.96±2.28, P < 0.05), and the incidence of gastrointestinal bleeding was significantly decreased (19.04% vs. 24.00%, P < 0.05), the incidence of VAP was significantly decreased (18.64% vs. 21.36%, P < 0.05), and the antibiotics accounted for a significant decrease (62.43% vs. 76.59%, P < 0.05), but there was no significant difference in the proportion of drugs and monthly average hospitalization expenses [drug ratio: 36.88% vs. 38.42%, monthly average hospitalization cost (ten thousand yuan): 4.36±0.57 vs. 4.39±0.49, both P > 0.05].
For the patients with tracheotomy and long-term MV of ICU, the enteral nutrition tolerance assessment standardized process management can improve the nutritional status, reduce the incidence of nosocomial infections, and improve the prognosis of the patients.
探讨肠内营养(EN)耐受性评估标准化流程管理对重症监护病房(ICU)行气管切开并长期机械通气(MV)患者医院感染及预后的影响。
进行一项前瞻性队列研究。选取2015年1月至2017年12月在常州市第一人民医院ICU因气管切开需长期MV的46例患者。以2016年6月30日为时间节点,将2015年1月1日至2016年6月30日入院的患者作为对照组(25例),2016年7月1日至2017年12月31日入院的患者作为观察组(21例)。两组均给予常规EN治疗及常规对症支持治疗。观察组患者给予EN耐受性标准化流程管理,并进行营养风险筛查评分。对照组则给予常规EN管理方案(护士常规向医生汇报后再采取进一步行动)。比较治疗30天内的营养支持相关指标(包括血清白蛋白、血清前白蛋白、血清胆碱酯酶)、EN喂养耐受性指标(30天内胃肠动力药物平均使用量、每位患者EN平均中断时间、胃肠道出血发生率)及预后相关指标[包括呼吸机相关性肺炎(VAP)发生率、月平均住院费用、药物比例、抗生素与药物比例]。
与对照组相比,观察组血清白蛋白、前白蛋白及胆碱酯酶显著升高[白蛋白(g/L):32.86±4.83 vs. 28.16±3.62,前白蛋白(mg/L):186.42±62.84 vs. 163.26±73.49,胆碱酯酶(U/L):3482.34±369.92 vs. 2986.86±491.49,均P<0.05],胃肠动力药物平均使用量显著减少(mg:11.20±3.86 vs. 15.23±5.68,P<0.05),每位患者EN平均中断时间显著延长(小时:6.38±3.59 vs. 4.96±2.28,P<0.05),胃肠道出血发生率显著降低(19.04% vs. 24.00%,P<0.05),VAP发生率显著降低(18.64% vs. 21.36%,P<0.05),抗生素占比显著降低(62.43% vs. 76.59%,P<0.05),但药物比例及月平均住院费用差异无统计学意义[药物比例:36.88% vs. 38.42%,月平均住院费用(万元):4.36±0.57 vs. 4.39±0.49,均P>0.05]。
对于ICU行气管切开并长期MV的患者,肠内营养耐受性评估标准化流程管理可改善营养状况,降低医院感染发生率,改善患者预后。